Co-founded Compass Innovation Labs alongside principal engineer to launch Compass AI, scaling generative AI tools to 17k+ agents.

Led full stack technical strategy for Compass AI product suite since its inception, shipping solutions ranging from marketing content automation to private inventory management.

Chief architect of the org's GenAI evaluation platform. Built a bespoke offline regression framework testing 300+ scenarios and an automated online monitoring system to proactively detect live interaction anomalies.

Built the 'Asset Resolution Service,' a micro-frontend deployment platform supporting 1,600+ annual releases. Reduced deployment lead time by 80% and mitigated incident risk via instant, one-click rollbacks.

Frontend Lead for the Media Library (central asset hub). Architected ingestion pipelines processing 1M+ annual images and videos.

Spearheaded M&A strategy to penetrate limited-license oligopoly markets (FL, NY, IL, AZ), securing critical medical and recreational cannabis retail and cultivation assets in states with strict regulatory caps.

Managed transformative transactions, including the $682M acquisition of PharmaCann (largest US cannabis M&A deal at the time) and the $53M strategic acquisition of Treadwell Nursery in Florida.

Key member of the investment team managing a $6B+ endowment. Executed on the sourcing, due diligence, and selection of top-tier external investment managers across diverse asset classes including Public Equities, Private Equity, Venture Capital, Hedge Funds, Real Estate, and Natural Resources.

Implemented a high-throughput blood sample screening assay for antibodies against arenaviruses.